The pharmaceutical industry is entering a new era where commercial success depends as much on data as it does on innovation. Launching a breakthrough therapy is no longer enough. Companies must understand physician behavior, personalize engagement, and make faster decisions across sales, medical affairs, and marketing.
This shift is reflected in Bain & Company’s Life Sciences Software Survey (n=98), which surveyed 98 senior life sciences executives responsible for commercial technology and software investments. The survey highlights how CRM platforms have evolved from simple sales management tools into strategic digital ecosystems that improve customer engagement, forecasting, and business performance.
The Survey Shows CRM Is Now a Boardroom Priority
Bain’s survey found that life sciences companies are prioritizing software investments that improve commercial effectiveness rather than simply replacing legacy systems. Executives increasingly value platforms that integrate physician engagement, medical affairs, analytics, AI, and omnichannel communication into a single workflow.
The findings align with broader industry trends. According to McKinsey, pharmaceutical companies that effectively deploy AI in commercial operations can unlock US$60–110 billion in annual value through better targeting, productivity, and customer engagement. Deloitte also reports that digital transformation remains one of the highest strategic investment priorities for global life sciences organizations.
Real Industry Numbers Confirm the CRM Transformation
The software market supporting healthcare commercialization continues to expand rapidly.
According to Towards Healthcare Research and Consulting, the global Healthcare Customer Relationship Management (CRM) market was valued at approximately US$ 20.78 billion in 2025 and is expected to exceed US$ 43.80 billion by 2035, growing at a CAGR of over 7.74%.
Within life sciences, Veeva Systems reported FY2026 revenue of over US$2.9 billion, reflecting strong demand from pharmaceutical and biotechnology companies for cloud-based commercial software. More than 1,000 life sciences customers use Veeva’s commercial and clinical applications worldwide.
Healthcare Leaders Want Intelligent CRM, Not Just Customer Databases
The Bain survey suggests that executives are moving beyond traditional CRM functionality.
Today’s healthcare leaders expect CRM platforms to:
- Predict physician prescribing behavior using AI.
- Recommend the next best customer interaction.
- Deliver personalized omnichannel engagement.
- Integrate commercial, medical, and market access data.
- Improve launch planning and demand forecasting.
- Reduce administrative workload for field representatives.
This evolution reflects the industry’s growing focus on productivity and customer experience rather than simply increasing sales calls.
Digital Engagement Is Permanently Changing Physician Relationships
Healthcare professionals are engaging with pharmaceutical companies differently than they did before the pandemic.
IQVIA reports that many physicians now prefer a hybrid engagement model, combining virtual meetings with in-person interactions. Digital channels—including email, webinars, remote detailing, and medical portals; have become routine parts of commercial engagement.
CRM platforms have become the foundation for coordinating these interactions while ensuring compliance, personalization, and consistent communication across every customer touchpoint.
Looking for data that supports your next business decision? Get a FREE sample tailored to your strategic priorities: https://www.towardshealthcare.com/download-sample/5876
The Business Impact Goes Beyond Sales
Modern CRM systems influence much more than commercial teams.
Accurate physician engagement data improves demand forecasting, enabling manufacturing teams to optimize production schedules and reduce inventory risks. Medical affairs teams gain better visibility into scientific discussions, while market access teams can identify regional opportunities more effectively.
For companies launching specialty drugs, biologics, oncology therapies, and cell and gene therapies, these insights translate into faster product adoption and improved patient access.
What the Survey Means for the Future
Although Bain’s survey included 98 executives, the respondents represent the decision-makers responsible for technology investments across global life sciences organizations. Their priorities indicate where the industry is heading.
Over the next few years, CRM platforms are expected to integrate generative AI, predictive analytics, real-world evidence, clinical trial recruitment, patient support programs, and commercial intelligence into a unified platform. Organizations that invest early in connected CRM ecosystems will be better positioned to improve operational efficiency, strengthen physician relationships, and accelerate the delivery of innovative therapies.
Key Industry Statistics
| Metric | Latest Data |
|---|---|
| Bain Life Sciences Software Survey | 98 senior executives (n=98) |
| Global healthcare CRM market value (2025) | US$ 20.78 billion |
| Expected Healthcare CRM market by 2030 | Over US$ 43.8 billion |
| Expected Healthcare CRM CAGR (2025–2030) | 7.74%+ |
| AI value opportunity in pharma (McKinsey) | US$60–110 billion annually |
| Veeva FY2026 revenue | Over US$2.9 billion |
| Veeva life sciences customers | 1,000+ organizations |
| Preferred HCP engagement | Hybrid (digital + face-to-face) |
Key Takeaway
Bain’s Life Sciences Software Survey (n=98) reinforces a clear message: CRM is no longer just a sales tool—it is becoming the digital backbone of pharmaceutical commercialization. Combined with industry data showing rapid CRM market growth, increasing AI adoption, and changing physician engagement preferences, the survey highlights that future competitive advantage will depend on how effectively life sciences companies use connected software to turn customer data into faster decisions, better engagement, and improved patient outcomes.
Get Easy Access
Access our exclusive, data-rich dashboard dedicated to the life science industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is a part of Towards Healthcare Research and Consulting is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium